期刊文献+

不同治法体内抗甲3(H_3N_2)亚型流感病毒作用的实验研究 被引量:6

Experimental Research on the Effects of Different Diaphoretic Therapeutic Methods Against Influenza A(H_3N_2) Viruses in Vivo
下载PDF
导出
摘要 目的:探讨辛凉解表、辛温解表及祛湿解表等不同治法在体内抗甲3(H3N2)亚型流感病毒的作用。方法:三种治法的代表方分别选择银翘散、桂枝麻黄各半汤和新加香薷饮,设正常对照组、阳性药物(病毒唑)组和三种治法组,分别观察不同治法对甲3(H3N2)亚型流感病毒小鼠肺炎的影响,对小鼠感染甲3(H3N2)亚型流感病毒的死亡保护作用和延长生命作用。结果:以肺指数为评价指标,三种不同治法组与模型对照组相比(P<0.01),差异有统计学意义;三种不同治法组之间比较以及三种不同治法组和阳性药物组之间比较,差异无统计学意义。不同处理组间死亡率比较和不同处理组间存活时间的比较,差异无统计学意义。结论:三种不同治法对甲3(H3N2)亚型流感病毒小鼠肺炎均有抑制作用,但三种不同治法之间以及三种不同治法和阳性药物之间作用并无差异性。三种治法对小鼠感染甲3(H3N2)亚型流感病毒的死亡保护作用和延长生命作用均不明显。 Objective: To explore the effects of different diaphoretic therapeutic principles (acrid and hot-natured drugs, acrid and cool-natured drugs and moisture-eliminating drugs) against influenza A (H3 N2 ) viruses in vivo. Methods: Yinqiao Powder, Guima Geban Decoction and Xinjia Xiangru Decoction were chosen to represent different diaphoretic therapeutic methods. NIH mice were divided randomly into the controlled group and the experimental group. The Experimental group included three decoction-treated mice and Ribavirin-treated mice. To observe the effects of three different principles on treating mice influenza A ( H3 N2 ) pneumonia, decreasing mortality of infected mice and prolonging the survival of mice infected with influenza A (H3 N2 ) viruses. Results: There were significant differences in the score of lung consolidation between decoction-treated mice and virusinfected mice (P〈 0.01). But there were no significant differences in SLC among three different deeoction-treated mice and between three different decoction-treated mice and Ribavirin-treated mice. Meanwhile the experiment also showed there were no significant differences in mice mortality and survival among respective groups. Conclusion: Three different principles all can relieve the seriousness of mice influenza A (H3 N2 ) pneumonia. But the effects of three different methods on mortality of infected mice and prolonging the survival of infected mice are not remarkable.
出处 《河南中医》 2007年第2期25-27,共3页 Henan Traditional Chinese Medicine
基金 国家自然科学基金资助项目(编号:39700184) 国家中医药管理局资助项目(编号:04-05JP46)
关键词 银翘散 桂枝麻黄各半汤 新加香薷饮 甲3(H3N2)亚型流感病毒 小鼠 Yinqiao Powder Guima Geban Decoction Xinjia Xiangru Decoction influenza A (H3N2) viruses mice
  • 相关文献

参考文献7

二级参考文献6

  • 1Lavanchy D. World Health Organization, 50 years of influenza surveillance: a challenge for the 21st century: meeting 17-19 February 1999, WHO, Geneva, Vaccine, 2002, 20(suppl 2) :s1-s4.
  • 2Nerome R, Nerome K, Tanabe N, et al. Perspectives on the characteristics and achievements of recent surveillance of influenza activity in Japan. Vaccine, 2002, 20(suppl 2) :s36-s43.
  • 3Shaw MW, Xu X, Li Y, et al. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology, 2002,303 : 1-8.
  • 4Jonathan S,Nguyen-Vantam, Hampson AW. The epidemiology and clinical impact of pandemic influenza. Vaccine, 2003, 21 : 1762-1768.
  • 5Klaus Stohr. The global agenda on influenza surveillance and control.Vaccine, 2003, 21 : 1744-1748.
  • 6P. Anne Underwood. Receptor binding characteristics of strains of the influenza Hong Kong subtype, using a periodate sensitivity test[J] 1985,Archives of Virology(1-2):53~61

共引文献384

同被引文献31

  • 1盛丹,黎敬波,刘进.辛温解表三方体内抗甲1(H1N1)亚型流感病毒的实验研究[J].现代中西医结合杂志,2007,16(1):25-27. 被引量:6
  • 2Turkulov V, Madle-Samardzi ja N. Influenza always present among us[J]. Med Prel,2000,3 (3/4) :154.
  • 3Bernd Sebastian Kamps, Christian Hoffmann, Wolfgang Preiser. Influenza Report, 2006, www. InfluenzaReport.com.
  • 4董丽波,张烨,温乐英,赵翔,黄维娟,蓝雨,郭俊峰,李梓,王敏,董婕,郭元吉,舒跃龙.1995~2005年中国H3N2亚型人流感病毒血凝素基因变异与流行相关性研究[J].病毒学报,2007,23(5):339-344. 被引量:35
  • 5Horimoto T,Kawaoka Y.Influenza: lessons from past pandemics warmings from current incidents [J].Nat Rev Microbiol, 2005,3 (8) : 591-600.
  • 6Barr IG,McCauley J,Cox N,et al.Epidemiologieal,antigenic and genetic characteristics of seasonal influenza A (H1N1),A (H3N2) and B influenza viruses:basis for the WHO recommend- ation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season [ J ].Vaccine, 2010,28 (5) : 1156-1167.
  • 7Westgeest KB,de Graaf M,Fourment M,et al.Genetic evolution of the neuraminidase of influenza A(H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution[J]. J Gen Viral, 2012,93 (Pt 9) : 1996-2007.
  • 8Sandbuhe MR,Westgeest KB,Gao J,et al.Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza vimses[Jl.Proc Natl Acad Sci U S A,2011,108(51 ) : 20748-20753.
  • 9Kilboume ED,Johansson BE,Grajower B.Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glyeoproteins[J]. Proe Natl Acad Sci U S A, 1990, 87(2): 786-790.
  • 10Tamura K, Peterson D, Peterson N, et al.MEGA5 : molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods [ J ]. Mol Biol Evol, 2011,28 (10) : 2731-2739.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部